2020 III期非小细胞肺癌的管理指南

2020-11-25 国外肿瘤科相关专家小组(统称) Crit Rev Oncol Hematol . 2020 Nov 7;157:103144.

III期非小细胞肺癌(NSCLC)是一组具有广泛异质性的疾病,需要多学科综合管理。本文主要针对III期非小细胞肺癌的管理提出了循证指导建议,内容涉及III期NSCLC的检查,分期,治疗以及随访等。

中文标题:

2020 III期非小细胞肺癌的管理指南

英文标题:

Management guidelines for stage III non-small cell lung cancer

发布日期:

2020-11-25

简要介绍:

III期非小细胞肺癌(NSCLC)是一组具有广泛异质性的疾病,需要多学科综合管理。本文主要针对III期非小细胞肺癌的管理提出了循证指导建议,内容涉及III期NSCLC的检查,分期,治疗以及随访等。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 III期非小细胞肺癌的管理指南.pdf)] GetToolGuiderByIdResponse(projectId=1, id=9c49a1c0020212db, title=2020 III期非小细胞肺癌的管理指南, enTitle=Management guidelines for stage III non-small cell lung cancer, guiderFrom=Crit Rev Oncol Hematol . 2020 Nov 7;157:103144., authorId=0, author=, summary=III期非小细胞肺癌(NSCLC)是一组具有广泛异质性的疾病,需要多学科综合管理。本文主要针对III期非小细胞肺癌的管理提出了循证指导建议,内容涉及III期NSCLC的检查,分期,治疗以及随访等。, cover=https://img.medsci.cn/2020126/1607185934374_2020535.jpg, journalId=0, articlesId=null, associationId=887, associationName=国外肿瘤科相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Wed Nov 25 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>III期非小细胞肺癌(NSCLC)是一组具有广泛异质性的疾病,需要多学科综合管理。本文主要针对III期非小细胞肺癌的管理提出了循证指导建议,内容涉及III期NSCLC的检查,分期,治疗以及随访等。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=276, tagName=非小细胞肺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=276, guiderKeyword=非小细胞肺癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5169, appHits=344, showAppHits=0, pcHits=929, showPcHits=4825, likes=3, shares=18, comments=23, approvalStatus=1, publishedTime=Sun Dec 06 00:50:34 CST 2020, publishedTimeString=2020-11-25, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Dec 06 00:32:20 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 20:16:16 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 III期非小细胞肺癌的管理指南.pdf)])
2020 III期非小细胞肺癌的管理指南.pdf
下载请点击:
评论区 (21)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1082409, encodeId=4a1b1082409aa, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:52:01 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005895, encodeId=a47b100589514, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58b85566832, createdName=ms4000000330710846, createdTime=Sat Aug 07 21:45:31 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005894, encodeId=bbb8100589401, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58b85566832, createdName=ms4000000330710846, createdTime=Sat Aug 07 21:45:06 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005893, encodeId=f59b1005893ab, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58b85566832, createdName=ms4000000330710846, createdTime=Sat Aug 07 21:44:50 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972999, encodeId=ac689e299946, content=有肺鳞癌的化疗指南吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39cb5519635, createdName=ms7000001966173497, createdTime=Sat Jun 12 09:06:50 CST 2021, time=2021-06-12, status=1, ipAttribution=)]
    2021-12-21 龙珠

    学习好资料!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1082409, encodeId=4a1b1082409aa, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:52:01 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005895, encodeId=a47b100589514, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58b85566832, createdName=ms4000000330710846, createdTime=Sat Aug 07 21:45:31 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005894, encodeId=bbb8100589401, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58b85566832, createdName=ms4000000330710846, createdTime=Sat Aug 07 21:45:06 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005893, encodeId=f59b1005893ab, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58b85566832, createdName=ms4000000330710846, createdTime=Sat Aug 07 21:44:50 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972999, encodeId=ac689e299946, content=有肺鳞癌的化疗指南吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39cb5519635, createdName=ms7000001966173497, createdTime=Sat Jun 12 09:06:50 CST 2021, time=2021-06-12, status=1, ipAttribution=)]
    2021-08-07 ms4000000330710846

    很好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1082409, encodeId=4a1b1082409aa, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:52:01 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005895, encodeId=a47b100589514, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58b85566832, createdName=ms4000000330710846, createdTime=Sat Aug 07 21:45:31 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005894, encodeId=bbb8100589401, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58b85566832, createdName=ms4000000330710846, createdTime=Sat Aug 07 21:45:06 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005893, encodeId=f59b1005893ab, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58b85566832, createdName=ms4000000330710846, createdTime=Sat Aug 07 21:44:50 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972999, encodeId=ac689e299946, content=有肺鳞癌的化疗指南吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39cb5519635, createdName=ms7000001966173497, createdTime=Sat Jun 12 09:06:50 CST 2021, time=2021-06-12, status=1, ipAttribution=)]
    2021-08-07 ms4000000330710846

    很有用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1082409, encodeId=4a1b1082409aa, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:52:01 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005895, encodeId=a47b100589514, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58b85566832, createdName=ms4000000330710846, createdTime=Sat Aug 07 21:45:31 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005894, encodeId=bbb8100589401, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58b85566832, createdName=ms4000000330710846, createdTime=Sat Aug 07 21:45:06 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005893, encodeId=f59b1005893ab, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58b85566832, createdName=ms4000000330710846, createdTime=Sat Aug 07 21:44:50 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972999, encodeId=ac689e299946, content=有肺鳞癌的化疗指南吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39cb5519635, createdName=ms7000001966173497, createdTime=Sat Jun 12 09:06:50 CST 2021, time=2021-06-12, status=1, ipAttribution=)]
    2021-08-07 ms4000000330710846

    很棒

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1082409, encodeId=4a1b1082409aa, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:52:01 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005895, encodeId=a47b100589514, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58b85566832, createdName=ms4000000330710846, createdTime=Sat Aug 07 21:45:31 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005894, encodeId=bbb8100589401, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58b85566832, createdName=ms4000000330710846, createdTime=Sat Aug 07 21:45:06 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005893, encodeId=f59b1005893ab, content=很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58b85566832, createdName=ms4000000330710846, createdTime=Sat Aug 07 21:44:50 CST 2021, time=2021-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972999, encodeId=ac689e299946, content=有肺鳞癌的化疗指南吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39cb5519635, createdName=ms7000001966173497, createdTime=Sat Jun 12 09:06:50 CST 2021, time=2021-06-12, status=1, ipAttribution=)]
    2021-06-12 ms7000001966173497

    有肺鳞癌的化疗指南吗

    1

    展开1条回复

拓展阅读

ASCO指南:IV期非小细胞肺癌的维持治疗(2009)

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2009-12-20

2010CCO 晚期非小细胞肺癌一线全身化疗

加拿大安大略癌症治疗中心(CCO,Cancer Care Ontario) · 2010-01-01

2010ESMO临床实践指南:早期和局部晚期(非转移性)非小细胞肺癌

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-03-01

2010ESMO临床实践指南:转移性非小细胞肺癌的诊断、治疗和随访

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-03-01